Evidence map›Paper›PMID 26113745›Full record

ArticleThe Australian and New Zealand journal of psychiatry2016

Cell proliferation is reduced in the hippocampus in schizophrenia.

Katherine M Allen, Samantha J Fung, Cynthia Shannon Weickert

Abstract read
In one paragraph

Article in The Australian and New Zealand journal of psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Katherine M AllenSchizophrenia Research Institute, Darlinghurst, NSW, Australia Neuroscience Research Australia, Randwick, NSW, Australia School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
Samantha J FungSchizophrenia Research Institute, Darlinghurst, NSW, Australia Neuroscience Research Australia, Randwick, NSW, Australia School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
Cynthia Shannon WeickertSchizophrenia Research Institute, Darlinghurst, NSW, Australia Neuroscience Research Australia, Randwick, NSW, Australia School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia c.weickert@neura.edu.au.

Funding

Brain Tissue Resource Centre for Alcohol ResearchR28AA012725 · NIAAA · UNIVERSITY OF SYDNEY · PI Greg Trevor Sutherland · 2012 to 2026
$7.0M
BRAIN TISSUE RESOURCE CENTER FOR ALCOHOL RESEARCHR24AA012725 · NIAAA · UNIVERSITY OF SYDNEY · PI KRIL, JILLIAN JUNE · 2000 to 2011
$2.2M
NIAAA NIH HHS R24 AA012725NIAAA NIH HHS R24AA012725NIAAA NIH HHS R28 AA012725
6 · The paper itself

Abstract

objectiveThe molecular and cellular basis of structural and functional abnormalities of the hippocampus found in schizophrenia is currently unclear. Postnatal neurogenesis contributes to hippocampal function in animal models and is correlated with hippocampal volume in primates. Reduced hippocampal cell proliferation has been previously reported in schizophrenia, which may contribute to hippocampal dysfunction.

methodWe measured the cell proliferation marker, Ki67, in post-mortem hippocampal tissue from patients with schizophrenia (n = 10) and matched controls (n = 16). Ki67-labelled cells were counted within the dentate gyrus and hilus on sections taken from the anterior hippocampus.

resultsWe replicated the finding of a significant reduction in Ki67+ cells/mm² in schizophrenia cases compared to controls (t24 = 2.1, p = 0.023). In our relatively small sample, we did not find a relationship between Ki67+ cells and age overall, or between Ki67 + cells and duration of illness or antipsychotic treatment in people with schizophrenia.

conclusionOur results confirm that reduced hippocampal cell proliferation may be present in schizophrenia. Restoring hippocampal neurogenesis may be a potential therapeutic target for the treatment of hippocampal dysfunction in schizophrenia.

Indexed as

Cell ProliferationAdultAgedAged, 80 and overCase-Control StudiesDentate GyrusFemaleHumansKi-67 AntigenMaleMiddle AgedSchizophreniaYoung AdultKi-67 AntigenhippocampusKi67Neurogenesisproliferationschizophrenia

Identifiers

PMID26113745
PMCPMC4843086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.